PARAWAN STALZER: Open Payments
NPI 1851552376 · HERNDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 13 payments from 8 companies in 2025. Trend: 2023 $34 · 2024 $0 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $224 |
| CSL Behring | 3 | $181 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $181 |
| GlaxoSmithKline, LLC. | 1 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Pharming Healthcare, Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $23 |
Products named: CIBINQO, NEFFY, Andembry, NUCALA, Haegarda, TAKHZYRO, Rhapsido, RUCONEST.
Industry payments across VA — which companies pay providers there.
